TY - JOUR
T1 - 17-Beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease
AU - Airoldi, Flavio
AU - Di Mario, Carlo
AU - Ribichini, Flavio
AU - Presbitero, Patrizia
AU - Sganzerla, Paolo
AU - Ferrero, Valeria
AU - Vassanelli, Corrado
AU - Briguori, Carlo
AU - Carlino, Mauro
AU - Montorfano, Matteo
AU - Biondi-Zoccai, Giuseppe G L
AU - Chieffo, Alaide
AU - Ferrari, Angela
AU - Colombo, Antonio
PY - 2005/9/1
Y1 - 2005/9/1
N2 - In this study we randomly compared the estradiol eluting stent (17-β-E) with phosphorylcholine (PC)-coated stents in native coronary arteries. The incidence of angiographic restenosis was 23% in the 17-β-E group and 31% in the PC group (p = 0.34). The major adverse cardiovascular event rates were also similar in the 2 groups (17% in the 17-β-E group vs 22% in the PC group, p = 0.47). The mid-term clinical and angiographic outcomes did not indicate superiority of the 17-β-E eluting stent over the control PC stent.
AB - In this study we randomly compared the estradiol eluting stent (17-β-E) with phosphorylcholine (PC)-coated stents in native coronary arteries. The incidence of angiographic restenosis was 23% in the 17-β-E group and 31% in the PC group (p = 0.34). The major adverse cardiovascular event rates were also similar in the 2 groups (17% in the 17-β-E group vs 22% in the PC group, p = 0.47). The mid-term clinical and angiographic outcomes did not indicate superiority of the 17-β-E eluting stent over the control PC stent.
UR - http://www.scopus.com/inward/record.url?scp=23944463886&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=23944463886&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2005.04.040
DO - 10.1016/j.amjcard.2005.04.040
M3 - Article
C2 - 16125491
AN - SCOPUS:23944463886
VL - 96
SP - 664
EP - 667
JO - American Journal of Cardiology
JF - American Journal of Cardiology
SN - 0002-9149
IS - 5
ER -